Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes.

Razi, Faraz; Haq, Adnaan; Tonne, Prabhu; Logendran, Maharatnam

Razi, Faraz; Haq, Adnaan; Tonne, Prabhu; Logendran, Maharatnam.

Afiliação

Razi F; Department of Paediatrics, Basingstoke and North Hampshire Hospital, Basingstoke, UK.
Haq A; Department of Ophthalmology, Leicester General Hospital, Leicester, UK.
Tonne P; Department of Ophthalmology, Northampton General Hospital, Northampton, UK.
Logendran M; Department of Ophthalmology, Northampton General Hospital, Northampton, UK.

Clin Ophthalmol ; 10: 313-9, 2016.

Article em En | MEDLINE | ID: mdl-26937168

Palavras-chave

Lucentis; long-term results; neovascular AMD

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Clin Ophthalmol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google